It’s either inaccurate — missing up to half of all cases — or requires expensive laboratories that are not widely available ...

Drugs to treat tuberculosis have been around for more than 75 years, yet it remains the world's top infectious disease killer ...

Texas Biomedical Research Institute has established a new $2 million Tuberculosis Innovation and Technology Fund supported by philanthropic investment to accelerate future TB discoveries, therapies ...

Dr. Tony Hu, originally from China, came to the United States in 2012 for his master's in chemistry and his doctorate in biological engineering at the University of Texas in Austin. After two years in ...

Venlo, the Netherlands, June 15, 2023 (GLOBE NEWSWIRE) -- QIAGEN (QGEN) (NYSE: QGEN; Frankfurt Prime Standard: QIA) welcomes the publication of a new, systematic review highlighting the unique value ...

Tuberculosis, or TB, an airborne bacterial respiratory infection, is one of humanity's oldest foes and is today the world's leading cause of death from infectious disease, claiming more than 1.2 ...

In a paper published today in the Journal of Clinical Investigation, a research team at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health reports developing a therapeutic ...

Researchers at Boston University have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) in patients hospitalized in Boston, suggesting that tuberculosis disease may ...

How could this technology impact TB diagnosis on a global level? There is a lot of global interest coming to coming to us. Now, we have many ongoing international or domestic collaborations that I ...